Xbrane Biopharma AB XBRANE
OMXSTO · Sweden · Health Technology
SEK 10.55-0.45 (-4.09%)
Market closed· · SEK · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · SEK · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Xbrane Biopharma AB (STU:7XB0) reports a mixed quarter with strategic advancements in Europe and the US, despite financial hurdles and competitive pressures.
Xbrane Biopharma AB (STU:7XB0) outlines cost reduction plans and pipeline progress amid competitive pressures and financial hurdles.
Xbrane Biopharma AB (FRA:7XB0) reports significant growth and strategic advancements despite facing pricing pressures and production hurdles.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.